Immunocore Holdings plc (IMCR) Operating cash flow 2021–2025
Immunocore Holdings plc (IMCR) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$10.7MFY2025 · since FY2021: -$143.1M → -$10.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$10.7M | -141.1% |
| FY2024 | $26.1M | +786.4% |
| FY2023 | $2.9M | +106.0% |
| FY2022 | -$49.2M | +65.6% |
| FY2021 | -$143.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice